These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35668201)

  • 1. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study.
    Nguyen M; LeWitt T; Pang Y; Bagnowski K; Espinosa ML; Choi J; Guitart J; Liszewski W; Zhou XA
    Arch Dermatol Res; 2023 Mar; 315(2):275-278. PubMed ID: 35668201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study.
    Ren Z; Chrisman LP; Pang Y; Nguyen M; Hooper MJ; LeWitt TM; Veon FL; Guitart J; Zhou XA
    Arch Dermatol Res; 2024 Jan; 316(2):74. PubMed ID: 38236413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
    Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
    Vij A; Duvic M
    Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator.
    Ottevanger R; van Beugen S; Evers AWM; Willemze R; Vermeer MH; Quint KD
    JAAD Int; 2022 Dec; 9():57-64. PubMed ID: 36147217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments.
    Herbosa CM; Semenov YR; Rosenberg AR; Mehta-Shah N; Musiek AC
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):995-1003. PubMed ID: 31630443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma.
    Wright A; Wijeratne A; Hung T; Gao W; Whittaker S; Morris S; Scarisbrick J; Beynon T
    J Pain Symptom Manage; 2013 Jan; 45(1):114-9. PubMed ID: 22917715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
    Hu M; Scheffel J; Elieh-Ali-Komi D; Maurer M; Hawro T; Metz M
    Clin Exp Med; 2023 Dec; 23(8):4177-4197. PubMed ID: 37555911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage.
    Navarro Matilla B; Ortiz Romero PL; Pujol Vallverdú RM; Combalia Escudero A; Zapata Paz I; González Barca E; Muniesa Montserrat C; Morillo Andújar M; Pérez Ferriols A; Román Curto C; Fernández de Misa Cabrera R; Hospital Gil M; Marín Niebla A; Rios Rull PJ; de la Cruz Vicente F; Izu Belloso RM; Martín García-Sancho A; Parera Amer ME; Córdoba Mascuñano R; Ramón Quiles MD; Saus Carreres A; Del Campo García R; Machan S; Viguera Ester P; Blanco Garnelo J
    Actas Dermosifiliogr; 2024 Feb; 115(2):119-129. PubMed ID: 37689349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin for the treatment of cutaneous T-cell lymphoma.
    Cheeley J; Sahn RE; DeLong LK; Parker SR
    J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature.
    Ottevanger R; van Beugen S; Evers AWM; Willemze R; Vermeer MH; Quint KD
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2377-2387. PubMed ID: 34331819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.